NASDAQ$SINT
SiNtx Technologies Inc · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
SiNtx Technologies Inc reported a net loss of $2.8 million for the first quarter of 2026.
SiNtx Technologies Inc recorded total revenue of $380,000 for the three months ended March 31, 2026, up 3% from the prior year. The company posted a net loss of $2.8 million and used $2.5 million in cash from operations. Management continues to focus on commercializing silicon nitride medical products while maintaining industrial revenue streams.
- Total revenue reached $380,000, including $300,000 from products and $80,000 from grants and contracts.
- Gross profit improved to $144,000 with a gross margin of 38%.
- Net loss widened to $2.8 million as operating expenses rose to $3.4 million.
- Cash and cash equivalents declined to $1.9 million from $4.1 million at year-end 2025.
Headline financials
Revenue & EPS history
SiNtx · Revenue · Quarterly
$380K
Forward guidance
The company expects revenue from newly cleared foot and ankle products to increase throughout 2026 while continuing to generate revenue from industrial operations.
Tailwinds
- FDA-cleared SiNAPTIC Foot & Ankle system began generating revenue in Q1 2026.
- ATM facility provides up to $5.7 million in additional capital capacity.
Headwinds
- Substantial doubt remains about ability to continue as a going concern.
- Ongoing net losses and cash burn continue to pressure liquidity.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2026
-2.4%
Avg return
Earnings day
-0.2%
Avg return
5 days after
-3.6%
Avg return
30 days after
39%
19 / 49 earnings
Positive
+37.8%
Q1 2024
Best reaction
-47.3%
Q3 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -5.5% | -7.7% | — | |
| Q4 2025 | -3.4% | -3.4% | +1.1% | |
| Q3 2025 | -10.5% | -3.8% | +7.6% | |
| Q2 2025 | +1.3% | +8.9% | +42.6% | |
| Q1 2025 | +1.1% | +3.8% | +21.1% | |
| Q4 2024 | -3.9% | -1.1% | +75.6% | |
| Q3 2024 | -19.3% | -24.2% | +20.8% | |
| Q2 2024 | -1.9% | +3.7% | -19.1% | |
| Q1 2024 | +37.8% | +112.5% | -40.5% | |
| Q4 2023 | +0.6% | -20.4% | -18.4% | |
| Q3 2023 | -15.8% | -12.1% | -20.2% | |
| Q2 2023 | -8.5% | -6.9% | -21.0% | |
| Q1 2023 | +3.5% | +4.9% | +6.3% | |
| Q4 2022 | -11.0% | -16.3% | -29.5% | |
| Q3 2022 | +0.3% | -1.0% | +0.0% | |
| Q2 2022 | +9.4% | +7.4% | -18.9% | |
| Q1 2022 | +5.8% | +10.5% | +31.6% | |
| Q4 2021 | -3.1% | -3.0% | -16.1% | |
| Q3 2021 | -1.9% | -2.9% | -27.4% | |
| Q2 2021 | -2.1% | -7.0% | -4.9% | |
| Q1 2021 | -1.4% | +7.9% | +12.2% | |
| Q4 2020 | -10.6% | -11.5% | -29.8% | |
| Q3 2020 | -8.0% | +5.1% | -1.1% | |
| Q2 2020 | +0.9% | +9.1% | -25.5% | |
| Q1 2020 | +1.7% | -4.0% | +4.8% | |
| Q4 2019 | +31.5% | +23.4% | +59.4% | |
| Q3 2019 | -4.4% | -18.8% | -16.0% | |
| Q2 2019 | +9.0% | -9.6% | +32.8% | |
| Q1 2019 | +6.7% | -5.1% | -32.8% | |
| Q4 2018 | -3.3% | -3.3% | -12.5% | |
| Q3 2018 | -8.1% | -13.4% | -18.7% | |
| Q2 2018 | -6.1% | -20.5% | -23.2% | |
| Q1 2018 | +9.4% | -0.9% | -6.8% | |
| Q4 2017 | -9.9% | -8.6% | -24.3% | |
| Q3 2017 | +4.5% | -0.5% | -17.9% | |
| Q2 2017 | -0.5% | -7.8% | -21.8% | |
| Q1 2017 | -0.5% | -7.8% | -21.8% | |
| Q3 2016 | +9.6% | +28.5% | -2.9% | |
| Q2 2016 | -12.9% | -10.8% | +18.2% | |
| Q1 2016 | -11.4% | — | — | |
| Q4 2015 | +7.1% | — | — | |
| Q3 2015 | -47.3% | — | — | |
| Q2 2015 | -8.9% | — | — | |
| Q1 2015 | -3.2% | — | — | |
| Q4 2014 | -13.5% | — | — | |
| Q3 2014 | -14.6% | — | — | |
| Q2 2014 | -6.5% | — | — | |
| Q1 2014 | +1.2% | — | — | |
| Q4 2013 | +0.7% | — | — | |
| Q2 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro